Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  thrombocytopenia
Trial Type:  Supportive care
Results 1-12 of 12 for your search:
Start Over
Eltrombopag Olamine in Treating Thrombocytopenia in Patients with Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Phase: Phase III, Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2011-0319, NCI-2011-03336, NCT01428635
Combination Chemotherapy with or without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients with Malignant Brain Tumors
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 to 75
Trial IDs: ONC-02019-L, NCI-2013-00781, CR00018679, CR00021317, CR00022743, CR00023930, eIRB #922, MR00041590, OHSU-7328, OHSU-922, OHSU-ONC-02059-L, CASE-CCF-6385, NCT00075387
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Relapsed Multiple Myeloma Undergoing Chemotherapy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 11-373, NCI-2012-00821, NCT01484314
Romiplostim in Increasing Low Platelet Counts in Patients with Multiple Myeloma Receiving Chemotherapy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: NYU 10-02429, NCI-2012-01327, 10-02429, NCT01676961
Lenalidomide and Eltrombopag Olamine in Treating Patients with Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2012-407, NCI-2013-01219, 115479, 12-007, RV--MDS-PI-0645, NCT01772420
Aminocaproic Acid versus Platelet Transfusions in Preventing Bleeding in Patients with Thrombocytopenia and Hematologic Malignancies
Phase: Phase II
Type: Supportive care
Age: Over 18
Trial IDs: WINSHIP2429-13, NCI-2014-01417, NCI-2014-01404, NCT02074436
Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 2012-0920, NCI-2013-02348, NCT01927731
Romiplostim or Observation in Treating Patients with Chemotherapy-Induced Thrombocytopenia
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 13-132, NCI-2014-00545, NCT02052882
Eltrombopag in MDS Patients with Thrombocytopenia
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: MCC-16523, NCI-2011-00784, QR 25807/1, NCT01286038
Romiplostim in Treating Patients with Slow Platelet Recovery after Umbilical Cord Blood Transplant
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: MT2012-17R, NCI-2014-00767, 2012LS089, NCT02046291
Modified Donor Stem Cells in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Phase: No phase specified
Type: Supportive care
Age: 21 and under
Trial IDs: 10082, NCI-2011-03241, NCT01200017
Start Over